Philips and Leading Network of Healthcare Centers and Clinics in Russia to Modernize the Country's Regional Healthcare Infrastructures

PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA) today announced the signing of a 10-year strategic partnership agreement with the Expert Group of Companies, one of Russia's leading network of healthcare centers and clinics, to jointly improve the efficiency of the delivery of patient care in Russia. As part of the multi-year agreement, which has a total value of approximately EUR 74 million, Philips will equip the Group's new clinics with healthcare solutions for high-quality diagnosis and treatment.

Innovative MRI and CT scanners, advanced ultrasound and angiography systems combined with integrated clinical informatics solutions will optimize clinical processes, improve workflows and reduce costs. As the technology partner, Philips will also provide its deep clinical expertise, consulting services and technology planning for multidisciplinary medical centers and specialized cardiac centers. Furthermore, Philips and the Expert Group of Companies have plans to develop joint educational initiatives in the areas of MRI, ultrasound and endovascular diagnostics.

"The strategic partnership agreement with Philips, a global leader in health technology, will make innovative solutions for diagnosis and treatment available to more patients in Russia," said Elena Latysheva, President of the Expert Group of Companies. "The Expert Group of Companies has ten years of experience in the medical industry in Russia. The integrated approach and advanced technologies for diagnostics and treatment that will be available in our centers will improve the standards of medical care. We are confident that the partnership with Philips will help us achieve our strategic goal to become one of the largest private healthcare networks in Russia by 2026."

"This long-term cooperation with the Expert Group of Companies furthers our mission to improve people's lives across the health continuum - from healthy lifestyle, disease prevention and early diagnosis to treatment and home care," said Arman Voskerchyan, CEO of Philips Russia and Central Asia. "We firmly believe that this cooperation will improve patient outcomes and help to develop high-tech medical care in Russia."

The partnership will aim to improve the provision of medical services in existing Expert diagnostic centers across the country as well as establishing new hospitals and developing new business models. The Expert Group of companies also considers joining public-private partnerships in the field of public health. It represents a new format of cooperation, bringing together consultancy for business development and providing innovative medical equipment for clinics. The Expert Group of Companies and Philips plan to jointly develop a long-term strategy and transformation program for existing Expert centers. Moreover, the companies will focus on the development of a regional network of 35 multidisciplinary medical centers to expand the range and scope of service provision.

Cardiovascular disease is one of the major challenges for Russia's healthcare system. The collaboration aims to develop and implement integrated programs for cardiology ranging from prevention and diagnosis, to treatment and home care. The partners will address doctors' training and the introduction of new therapy methods into clinical practice.

The Expert Group of Companies aims to focus on the development of cooperation models between governmental and private medical institutions in the field of endovascular diagnostics and treatment across Russia. Pilot public-private partnership projects will be implemented in the Russian regions of Lipetsk, Voronezh and Yaroslavl, which are collectively home to more than five million people.

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. The Company leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the Company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. The Company's health technology portfolio generated 2015 sales of EUR 16.8 billion and employs approximately 70,000 employees with sales and services in more than 100 countries.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...